{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T23:30:08Z","timestamp":1781220608585,"version":"3.54.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,7,7]],"date-time":"2015-07-07T00:00:00Z","timestamp":1436227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s11882-015-0550-0","type":"journal-article","created":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T01:02:54Z","timestamp":1436144574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Hymenoptera Anaphylaxis and C-kit Mutations: An Unexpected Association"],"prefix":"10.1007","volume":"15","author":[{"given":"Patrizia","family":"Bonadonna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Bonifacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Zanotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,7]]},"reference":[{"key":"550_CR1","first-page":"54","volume-title":"WHO classification of tumors of hematopoietic and lymphoid tissues","year":"2008","unstructured":"Horny HP et al., editors. WHO classification of tumors of hematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008. p. 54\u201363.","edition":"4"},{"key":"550_CR2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","volume":"37","author":"P Valent","year":"2007","unstructured":"Valent P et al. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Investig. 2007;37:435\u201353.","journal-title":"Eur J Clin Investig"},{"key":"550_CR3","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2008.11.018","volume":"123","author":"P Bonadonna","year":"2009","unstructured":"Bonadonna P et al. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol. 2009;123:680\u20136.","journal-title":"J Allergy Clin Immunol"},{"key":"550_CR4","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/j.1398-9995.2009.02108.x","volume":"64","author":"P Bonadonna","year":"2009","unstructured":"Bonadonna P et al. How much specific is the association between hymenoptera venom allergy and mastocytosis? Allergy. 2009;64:1379\u201382.","journal-title":"Allergy"},{"key":"550_CR5","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","volume":"125","author":"I Alvarez-Twose","year":"2010","unstructured":"Alvarez-Twose I et al. Clinical, biological and molecular characteristics of systemic mast cell disorders presenting with severe mediator-related symptoms. J Allergy Clin Immunol. 2010;125:1269\u201378.","journal-title":"J Allergy Clin Immunol"},{"key":"550_CR6","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3324\/haematol.2010.034553","volume":"96","author":"R Zanotti","year":"2011","unstructured":"Zanotti R et al. Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis. Haematologica. 2011;96:482\u20134.","journal-title":"Haematologica"},{"key":"550_CR7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.iac.2014.01.003","volume":"34","author":"K Brockow","year":"2014","unstructured":"Brockow K. Epidemiology, prognosis, and risk factors in mastocytosis. Immunol Allergy Clin N Am. 2014;34:283\u201395.","journal-title":"Immunol Allergy Clin N Am"},{"key":"550_CR8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jaci.2012.11.040","volume":"131","author":"R Zanotti","year":"2013","unstructured":"Zanotti R et al. Somatic D816 KIT mutation in a case of adult onset familial mastocytosis. J Allergy Clin Immunol. 2013;131:605\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"550_CR9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2141.2007.06619.x","volume":"138","author":"A Orfao","year":"2007","unstructured":"Orfao A, Garcia-Montero AC, Sanchez L, Escribano L. Recent advances in the understanding of mastocytosis: the role of KIT mutations. Br J Haematol. 2007;138:12\u201330.","journal-title":"Br J Haematol"},{"key":"550_CR10","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jaci.2012.10.015","volume":"131","author":"JJ Doormaal van","year":"2013","unstructured":"van Doormaal JJ et al. Prevalence of indolent systemic mastocytosis in a Dutch region. J Allergy Clin Immunol. 2013;131:1429\u201331.","journal-title":"J Allergy Clin Immunol"},{"key":"550_CR11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/bjh.12916","volume":"166","author":"SS Cohen","year":"2014","unstructured":"Cohen SS et al. Epidemiology of systemic mastocytosis in Denmark. Br J Haematol. 2014;166:521\u20138.","journal-title":"Br J Haematol"},{"key":"550_CR12","unstructured":"Bonifacio M, et al. Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. Haematologica (EHA annual meeting abstracts). 2013;98(s1):348."},{"key":"550_CR13","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000096442","volume":"142","author":"K Sonneck","year":"2006","unstructured":"Sonneck K et al. Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: monoclonal mast cell activation syndrome. Int Arch Allergy Immunol. 2006;142:158\u201364.","journal-title":"Int Arch Allergy Immunol"},{"key":"550_CR14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","volume":"157","author":"P Valent","year":"2012","unstructured":"Valent P et al. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int Arch Allergy Immunol. 2012;157:215\u201325. Consensus paper from a group of experts defining criteria for diagnosis of mast cell disorders and proposing a global unifying classification of all mast cell disorders. These criteria help to diagnose mast cell activation syndromes.","journal-title":"Int Arch Allergy Immunol"},{"key":"550_CR15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/all.12126","volume":"68","author":"P Valent","year":"2013","unstructured":"Valent P. Mast cell activation syndromes: definition and classification. Allergy. 2013;68:417\u201324.","journal-title":"Allergy"},{"key":"550_CR16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jaci.2013.06.020","volume":"133","author":"I Alvarez-Twose","year":"2014","unstructured":"Alvarez-Twose I et al. Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM. J Allergy Clin Immunol. 2014;133:520\u20138. Very interesting study where the authors underline that patients with Indolent Systemic Mastocytosis without skin lesions associated with insect-induced anaphylaxis present very characteristic clinical and serological features compared to other patients with ISM.","journal-title":"J Allergy Clin Immunol"},{"key":"550_CR17","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood-2006-06-028100","volume":"110","author":"C Akin","year":"2007","unstructured":"Akin C et al. Demonstration of an aberrant mast cell population with clonal markers in a subset of patients with \u201cidiopathic\u201d anaphylaxis. Blood. 2007;110:2331\u20133.","journal-title":"Blood"},{"key":"550_CR18","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1038\/leu.2013.227","volume":"27","author":"A Pardanani","year":"2013","unstructured":"Pardanani A et al. Clonal mast cell disease not meeting WHO criteria for diagnosis of mastocytosis: clinicopathologic features and comparison with indolent mastocytosis. Leukemia. 2013;27:2091\u20134.","journal-title":"Leukemia"},{"key":"550_CR19","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.clinthera.2013.04.001","volume":"35","author":"M Picard","year":"2013","unstructured":"Picard M, Giavina-Bianchi P, Mezzano V, Castells M. Expanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes. Clin Ther. 2013;35:548\u201362.","journal-title":"Clin Ther"},{"key":"550_CR20","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/cea.12369","volume":"44","author":"T G\u00fclen","year":"2014","unstructured":"G\u00fclen T, H\u00e4gglund H, Sander B, Dahl\u00e9n B, Nilsson G. The presence of mast cell clonality in patients with unexplained anaphylaxis. Clin Exp Allergy. 2014;44:1179\u201387.","journal-title":"Clin Exp Allergy"},{"key":"550_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.b.10072","volume":"58","author":"L Escribano","year":"2004","unstructured":"Escribano L et al. Immunophenotypic analysis of mast cells in mastocytosis: when and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA). Cytometry B Clin Cytom. 2004;58:1\u20138.","journal-title":"Cytometry B Clin Cytom"},{"key":"550_CR22","doi-asserted-by":"crossref","unstructured":"De Matteis G, et al. The impact of sensitive KIT D816V detection on recognition of indolent systemic mastocytosis. Leuk Res. 2014.","DOI":"10.1016\/j.leukres.2014.11.029"},{"key":"550_CR23","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/modpathol.2011.84","volume":"24","author":"L S\u00e1nchez-Mu\u00f1oz","year":"2011","unstructured":"S\u00e1nchez-Mu\u00f1oz L et al. Evaluation of the WHO criteria for the classification of patients with mastocytosis. Mod Pathol. 2011;24:1157\u201368.","journal-title":"Mod Pathol"},{"key":"550_CR24","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1182\/blood-2009-02-205237","volume":"113","author":"KH Lim","year":"2009","unstructured":"Lim KH et al. Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood. 2009;113:5727\u201336.","journal-title":"Blood"},{"key":"550_CR25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000329218","volume":"157","author":"F Wimazal","year":"2012","unstructured":"Wimazal F, Geissler P, Shnawa P, Sperr WR, Valent P. Severe life-threatening or disabling anaphylaxis in patients with systemic mastocytosis: a single-center experience. Int Arch Allergy Immunol. 2012;157:399\u2013405.","journal-title":"Int Arch Allergy Immunol"},{"key":"550_CR26","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/jcp.2003.014860","volume":"57","author":"HP Horny","year":"2004","unstructured":"Horny HP, Sotlar K, Sperr WR, Valent P. Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge. J Clin Pathol. 2004;57:604\u20138.","journal-title":"J Clin Pathol"},{"key":"550_CR27","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","volume":"92","author":"H Nagata","year":"1995","unstructured":"Nagata H et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci U S A. 1995;92:10560\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"550_CR28","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0145-2126(01)00028-5","volume":"25","author":"BJ Longley","year":"2001","unstructured":"Longley BJ, Reguera MJ, Ma Y. Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy. Leuk Res. 2001;25:571\u20136.","journal-title":"Leuk Res"},{"key":"550_CR29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cellsig.2007.10.013","volume":"20","author":"S Iwaki","year":"2008","unstructured":"Iwaki S, Spicka J, Tkaczyk C, Jensen BM, Furumoto Y, Charles N, et al. Kit- and Fc epsilonRI-induced differential phosphorylation of the transmembrane adaptor molecule NTAL\/LAB\/LAT2 allows flexibility in its scaffolding function in mast cells. Cell Signal. 2008;20:195\u2013205.","journal-title":"Cell Signal"},{"key":"550_CR30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000083954","volume":"136","author":"S Florian","year":"2005","unstructured":"Florian S et al. Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes. Int Arch Allergy Immunol. 2005;136:273\u201380.","journal-title":"Int Arch Allergy Immunol"},{"key":"550_CR31","doi-asserted-by":"crossref","unstructured":"Gonzalez\u00a0de\u00a0Olano D et al. Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA). Clin Exp Allergy. 2007;37:1547\u201355.","DOI":"10.1111\/j.1365-2222.2007.02804.x"},{"key":"550_CR32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/cea.12225","volume":"44","author":"T Gulen","year":"2014","unstructured":"Gulen T, Hagglund H, Dahlen B, Nilsson G. High prevalence of anaphylaxis in patients with systemic mastocytosis: a single-centre experience. Clin Exp Allergy. 2014;44:121\u20139.","journal-title":"Clin Exp Allergy"},{"key":"550_CR33","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","volume":"63","author":"K Brockow","year":"2008","unstructured":"Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy. 2008;63:226\u201332.","journal-title":"Allergy"},{"key":"550_CR34","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/all.12437","volume":"69","author":"A Muraro","year":"2014","unstructured":"Muraro A et al. EAACI Food Allergy and Anaphylaxis Guidelines Group. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014;69:1026\u201345.","journal-title":"Allergy"},{"key":"550_CR35","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S1081-1206(10)61086-1","volume":"97","author":"P Lieberman","year":"2006","unstructured":"Lieberman P et al. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol. 2006;97:596\u2013602.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"550_CR36","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.4049\/jimmunol.170.7.3835","volume":"170","author":"RT Strait","year":"2003","unstructured":"Strait RT, Morris SC, Smiley K, Urban Jr JF, Finkelman FD. IL-4 exacerbates anaphylaxis. J Immunol. 2003;170:3835\u201342.","journal-title":"J Immunol"},{"key":"550_CR37","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.coi.2008.09.005","volume":"20","author":"BM Vonakis","year":"2008","unstructured":"Vonakis BM, Saini SS. New concepts in chronic urticaria. Curr Opin Immunol. 2008;20:709\u201316.","journal-title":"Curr Opin Immunol"},{"key":"550_CR38","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/ACI.0b013e32830638c5","volume":"8","author":"BM Bil\u00f2","year":"2008","unstructured":"Bil\u00f2 BM, Bonifazi F. Epidemiology of insect-venom anaphylaxis. Curr Opin Allergy Clin Immunol. 2008;8:330\u20137.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"550_CR39","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/02770906609106941","volume":"3","author":"H Mueller","year":"1966","unstructured":"Mueller H. Diagnosis and treatment of insect sensitivity. J Asthma Res. 1966;3:331.","journal-title":"J Asthma Res"},{"key":"550_CR40","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1398-9995.2006.01077.x","volume":"61","author":"MG Severino","year":"2006","unstructured":"Severino MG, Campi P, Macchia D, Manfredi M, Turillazzi S, Spadolini I, et al. European Polistes venom allergy. Allergy. 2006;61:860\u20133.","journal-title":"Allergy"},{"key":"550_CR41","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0091-6749(83)90630-9","volume":"72","author":"UR M\u00fcller","year":"1983","unstructured":"M\u00fcller UR, Horat W, W\u00fcthrich B, Conroy M, Reisman RE. Anaphylaxis after Hymenoptera sting in three patients with urticaria pigmentosa. J Allergy Clin Immunol. 1983;72:685\u20139.","journal-title":"J Allergy Clin Immunol"},{"key":"550_CR42","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2796.1993.tb00984.x","volume":"233","author":"JW Kors","year":"1993","unstructured":"Kors JW, van Doormaal JJ, de Monchy JG. Anaphylactoid shock following Hymenoptera sting as a presenting symptom of systemic mastocytosis. J Intern Med. 1993;233:255\u20138.","journal-title":"J Intern Med"},{"key":"550_CR43","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0091-6749(97)70314-2","volume":"99","author":"JNK Oude Elberink","year":"1997","unstructured":"Oude Elberink JNK, de Moncky JGR, Kors JW, van Doormaal JJ, Dubois AE. Fatal anaphylaxis after a yellow jacket sting, despite venom immunotherapy, in two patients with mastocytosis. J Allergy Clin Immunol. 1997;99:153\u20134.","journal-title":"J Allergy Clin Immunol"},{"key":"550_CR44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0091-6749(97)70188-X","volume":"100","author":"M Fricker","year":"1997","unstructured":"Fricker M, Helbling A, Schwartz L, M\u00fcller U. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients. J Allergy Clin Immunol. 1997;100:11\u20135.","journal-title":"J Allergy Clin Immunol"},{"key":"550_CR45","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1046\/j.1365-2133.1999.03214.x","volume":"141","author":"T Biedermann","year":"1999","unstructured":"Biedermann T, Ru\u00ebff F, Sander CA, Przybilla B. Mastocytosis associated with severe wasp sting anaphylaxis detected by elevated serum mast cell tryptase levels. Br J Dermatol. 1999;141:1110\u20132.","journal-title":"Br J Dermatol"},{"key":"550_CR46","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11882-014-0450-8","volume":"14","author":"A Matito","year":"2014","unstructured":"Matito A et al. Anaphylaxis as a clinical manifestation of clonal mast cell disorders. Curr Allergy Asthma Rep. 2014;14:450.","journal-title":"Curr Allergy Asthma Rep"},{"key":"550_CR47","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1046\/j.1365-2222.2003.01755.x","volume":"33","author":"G Haeberli","year":"2003","unstructured":"Haeberli G, Bronnimann M, Hunziker T, Muller U. Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy. Clin Exp Allergy. 2003;33:1216\u201320.","journal-title":"Clin Exp Allergy"},{"key":"550_CR48","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaci.2009.08.027","volume":"129","author":"F Rueff","year":"2009","unstructured":"Rueff F et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase- a study of the European Academy of Allergology and Clinical Immunology Interest Group of Insect venom hypersensitivity. J Allergy Clin Immunol. 2009;129:1047\u201354.","journal-title":"J Allergy Clin Immunol"},{"key":"550_CR49","first-page":"288","volume":"24","author":"P Bonadonna","year":"2014","unstructured":"Bonadonna P, Lombardo C, Zanotti R. Mastocytosis and allergic diseases. J Investig Allergol Clin Immunol. 2014;24:288\u201397.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"550_CR50","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/ACI.0b013e32833b280c","volume":"10","author":"P Bonadonna","year":"2010","unstructured":"Bonadonna P, Zanotti R, M\u00fcller U. Mastocytosis and insect venom allergy. Curr Opin Allergy Clin Immunol. 2010;10:347\u201353.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"550_CR51","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaci.2012.12.1578","volume":"132","author":"B Anrooij Van","year":"2013","unstructured":"Van Anrooij B et al. Higher mast cell load decreases the risk of Hymenoptera venom-induced anaphylaxis in patients with mastocytosis. J Allergy Clin Immunol. 2013;132:125\u201330. Very good study that confirm that HVA-induced anaphylaxis is rare in patients with aggressive subtypes of SM, who harbor the highest mast cell load; this observation challenges the opinion that the risk of hymenoptera venom anaphylaxis increases with increasing mast cell load.","journal-title":"J Allergy Clin Immunol"},{"key":"550_CR52","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1398-9995.2010.02477.x","volume":"66","author":"M Niedoszytko","year":"2011","unstructured":"Niedoszytko M et al. Gene expression profile, pathways, and transcriptional system regulation in indolent systemic mastocytosis. Allergy. 2011;66:229\u201337.","journal-title":"Allergy"},{"key":"550_CR53","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaci.2009.10.020","volume":"125","author":"C Teodosio","year":"2010","unstructured":"Teodosio C et al. Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes. J Allergy Clin Immunol. 2010;125:719\u201326.","journal-title":"J Allergy Clin Immunol"},{"key":"550_CR54","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.iac.2014.01.011","volume":"34","author":"M Rossini","year":"2014","unstructured":"Rossini M et al. Bone involvement and osteoporosis in mastocytosis. Immunol Allergy Clin N Am. 2014;34:383\u201396.","journal-title":"Immunol Allergy Clin N Am"},{"key":"550_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.b.10072","volume":"58B","author":"L Escribano","year":"2004","unstructured":"Escribano L et al. Immunophenotypic analysis of mast cells in mastocytosis: when and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA). Cytometry Part B. 2004;58B:1\u20138.","journal-title":"Cytometry Part B"},{"key":"550_CR56","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/cyto.b.20606","volume":"80","author":"O Perbellini","year":"2011","unstructured":"Perbellini O et al. Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disorders. Cytometry B Clin Cytom. 2011;80:362\u20138.","journal-title":"Cytometry B Clin Cytom"},{"key":"550_CR57","doi-asserted-by":"crossref","unstructured":"Arock M, et al. KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis. Leukemia. 2015.","DOI":"10.1038\/leu.2015.24"},{"key":"550_CR58","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/all.12436","volume":"69","author":"P Valent","year":"2014","unstructured":"Valent P et al. Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis. Allergy. 2014;69:1267\u201374. This very important paper proposed for the first time a very useful algorythm for patient with suspected mastocytosis and without skin lesions including also patients with tryptase levels lower than 15-20 ng\/mL. Screening includes clinical symptoms, characteristic of anaphylaxis (REMA score) and evaluation of KIT mutation in the peripheral blood.","journal-title":"Allergy"},{"key":"550_CR59","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jaci.2014.06.031","volume":"135","author":"S Broesby-Olsen","year":"2015","unstructured":"Broesby-Olsen S, Mastocytosis Centre Odense University Hospital (MastOUH) and Odense Research Centre for Anaphylaxis, et al. Recognizing mastocytosis in patients with anaphylaxis: value of KIT D816V mutation analysis of peripheral blood. J Allergy Clin Immunol. 2015;135:262\u20134.","journal-title":"J Allergy Clin Immunol"},{"key":"550_CR60","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/j.1398-9995.2011.02659.x","volume":"66","author":"D Bokanovic","year":"2011","unstructured":"Bokanovic D, Aberer W, Griesbacher A, Sturm GJ. Prevalence of hymenoptera venom allergy and poor adherence to immunotherapy in Austria. Allergy. 2011;66:1395\u20136.","journal-title":"Allergy"},{"key":"550_CR61","first-page":"372","volume":"36","author":"C Incorvaia","year":"2004","unstructured":"Incorvaia C et al. Prevalence of allergic reactions to Hymenoptera stings in northern Italy. Eur Ann Allergy Clin Immunol. 2004;36:372\u20134.","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"550_CR62","doi-asserted-by":"crossref","unstructured":"Zanotti R, et al. Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels. J Allergy Clin Immunol. 2015.","DOI":"10.1016\/j.jaci.2014.11.035"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-015-0550-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-015-0550-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-015-0550-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T20:48:44Z","timestamp":1566938924000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-015-0550-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,7]]},"references-count":62,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["550"],"URL":"https:\/\/doi.org\/10.1007\/s11882-015-0550-0","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,7]]},"article-number":"49"}}